Catheter Precision kündigt Privatplatzierung von Aktien im Wert von 2,18 Millionen US-Dollar an

Reuters
Feb 07
Catheter Precision kündigt Privatplatzierung von Aktien im Wert von 2,18 Millionen US-Dollar an

Catheter Precision Inc. hat eine Privatplatzierung angekündigt und verkauft dabei rund 393.000 neue Stammaktien zu einem Preis von 1,43 US-Dollar pro Aktie. Zudem werden etwa 1.617 Vorzugsaktien der Serie C-1 ausgegeben, die in bis zu 1,13 Millionen Stammaktien wandelbar sind. Die Bruttoerlöse der ersten Platzierungsrunde belaufen sich auf etwa 2,2 Millionen US-Dollar. Das Unternehmen plant, die Mittel vor allem zur Schuldentilgung sowie für allgemeine Unternehmenszwecke und die Restrukturierung des bestehenden Kathetergeschäfts zu verwenden.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Catheter Precision Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001437749-26-003387), on February 06, 2026, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10